KYMERA THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
KYMERA THERAPEUTICS, INC. (KYMR) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $46.47 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2025-02-27
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $46.47M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $33.71M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $32.32M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $25.96M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2024-12-31 | $46.47M 10-K · filed 2025-02-27 |
| 2023-12-31 | $33.71M 10-K · filed 2025-02-27 |
| 2022-12-31 | $32.32M 10-K · filed 2024-02-22 |
| 2021-12-31 | $25.96M 10-K · filed 2023-02-23 |
| 2020-12-31 | $15.62M 10-K · filed 2022-02-24 |
| 2019-12-31 | $15.01M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |